Table 1.
Type-specific HPV prevalence and overall HPV prevalence in healthy women from mainland, stratified by geographical region
| HPV type | Amount prevalence | North China | Northeast | East China | Central China | Southwest | Northwest | South China |
|---|---|---|---|---|---|---|---|---|
| HPV ration | 14.3 (13.1, 15.5) | 14.5 (11.0,17.9) | 12.8 (8.6,17.0) | 15.6 (13.4,17.8) | 19.8 (15.4,24.2) | 13.3 (10.9,15.8) | 12.7 (6.3,19.0) | 12.1 (10.6,13.6) |
| HR HPV | 11.3 (10.5,12.2) | 10.8 (7.1,14.6) | 10.3 (7.5,13.1) | 11.7 (10.8,12.6) | 15.1 (11.6,18.7) | 9.2 (6.5,11.9) | 9.6 (6.3,13.0) | 11.6 (10.0,13.2) |
| LR HPV | 2.7 (2.3,3.2) | 2.3 (1.4,3.2) | 2.0 (1.1,2.9) | 2.9 (1.9,3.9) | 4.8 (2.9,6.7) | 3.1 (0.9,5.4) | 1.7 (1.1,2.3) | 2.5 (1.3,3.6) |
| HPV6/11 | 0.8 (0.6,0.9) | 0.6 (0.3,0.9) | 0.7 (0.4,0.9) | 0.9 (0.7,1.2) | 0.5 (0.1,0.9) | 0.5 (0.4,0.6) | 0.9 (0.3,1.5) | 0.8 (0.5,1.0) |
| HPV16 | 2.6 (2.4,2.9) | 4.1 (3.1,5.1) | 3.0 (1.8,4.3) | 2.2 (2.0,2.5) | 3.9 (2.5,5.4) | 2.7 (1.7,3.6) | 5.3 (3.9,6.6) | 1.8 (1.6,2.1) |
| HPV52 | 2.4 (2.1,2.7) | 1.5 (0.8,2.2) | 2.0 (1.6,2.4) | 2.8 (2.5,3.2) | 2.5 (1.4,3.7) | 2.1 (1.3,3.0) | 1.0 (0.8,1.3) | 2.7 (2.3,3.2) |
| HPV58 | 1.7 (1.6,1.9) | 2.1 (1.5,2.7) | 1.6 (1.0,2.2) | 1.8 (1.7,2.0) | 2.3 (1.8,2.8) | 1.6 (1.2,1.9) | 2.0 (0.8,3.2) | 1.2 (1.1,1.4) |
| HPV18 | 0.9 (0.8,1.0) | 1.0 (0.7,1.4) | 0.9 (0.7,1.1) | 0.9 (0.8,1.0) | 1.3 (0.7,2.0) | 0.7 (0.4,1.0) | 1.1 (0.2,2.1) | 0.8 (0.6,0.9) |
| HPV33 | 0.8 (0.7, 0.8) | 1.1 (0.9,1.3) | 0.8 (0.5,1.1) | 0.9 (0.8,1.0) | 1.0 (0.7,1.2) | 0.8 (0.5,1.0) | 0.5 (0.3,0.7) | 0.5 (0.4,0.6) |
| HPV51 | 0.7 (0.6, 0.8) | 0.7 (0.3,1.0) | 0.4 (0.1,0.7) | 0.7 (0.5,0.8) | 1.3 (0.4,2.3) | 0.6 (0.4,0.9) | 0.7 (0.1,1.3) | 0.7 (0.5,0.8) |
| HPV39 | 0.7 (0.6, 0.8) | 0.7 (0.3,1.0) | 0.9 (0.4,1.3) | 0.6 (0.4,0.7) | 0.7 (0.4,1.0) | 0.8 (0.6,1.0) | 1.0 (0.6,1.3) | 0.7 (0.5,0.8) |
| HPV68 | 0.7 (0.6,0.8) | 0.6 (0.4,0.7) | 0.6 (0.3,0.8) | 0.9 (0.7,1.1) | 0.0.8 (0.4,1.2) | 0. 6 (0.3,0.8) | 0.42 (0.22,0.6) | 0.5 (0.4,0.6) |
| HPV31 | 0.6 (0.5,0.7) | 0.7 (0.5,1.0) | 0.6 (0.3,0.9) | 0.7 (0.6,0.8) | 0.7 (0.4,1.0) | 0.5 (0.3,0.7) | 0.4 (0.2,0.5) | 0.4 (0.3,0.4) |
| HPV56 | 0.6 (0.5,0.6) | 0.7 (0.5,0.9) | 0.3 (0.1,0.5) | 0.5 (0.4,0.6) | 0.6 (0.2,0.9) | 0.8 (0.5,1.1) | 1.2 (1.1,1.3) | 0.4 (0.3,0.5) |
| HPV66 | 0.5 (0.4, 0.6) | 0.8 (0.7,1.0) | 0.3 (0.1,0.5) | 0.5 (0.4,0.6) | 1.0 (0.3,1.6) | 0.4 (0.3,0.5) | 0.5 (0.2,0.9) | 0.4 (0.3,0.5) |
| HPV6 | 0.43 (0.35,0.50) | 0.29 (0.11,0.46) | 0.35 (0.20,0.50) | 0.45 (0.31,0.60) | 0.36 (0.09,0.62) | 0.28 (0.12,0.44) | 0.61 (0.23,0.99) | 0.48 (0.32,0.65) |
| HPV59 | 0.36 (0.31,0.40) | 0.37 (0.25,0.49) | 0.27 (0.10,0.44) | 0.38 (0.31,0.45). | 0.61 (0.24,0.98) | 0.28 (0.14,0.42) | 0.65 (0.01,1.28) | 0.29 (0.22,0.35) |
| HPV11 | 0.34 (0.28, 0.40) | 0.34 (0.17,0.52) | 0.24 (0.06,0.41) | 0.45 (0.30,0.60) | 0.51 (0.17,0.84) | 0.26 (0.13,0.39) | 0.36 (0.15,0.57) | 0.25 (0.17,0.34) |
| HPV42 | 0.27 (0.22,0.32) | 0.22 (0.10,0.34) | 0.69 (0.01,1.48) | 0.34 (0.25,0.44) | 0.21 (0.04,0.39) | 0.21 (0.06,0.36) | 0.29 (0.24,0.35) | 0.24 (0.09,0.39) |
| HPV35 | 0.26 (0.22,0.31) | 0.22 (0.06,0.38) | 0.19 (0.09,0.28) | 0.30 (0.21,0.40) | 0.36 (0.12,0.60) | 0.13 (0.06,0.20) | 0.91 (0.31,1.51) | 0.23 (0.17,0.29) |
| HPV45 | 0.24 (0.20,0.28) | 0.18 (0.12,0.24) | 0.15 (0.09,0.22) | 0.23 (0.16,0.30) | 0.27 (0.15,0.39) | 0.19 (0.08,0.30) | 0.19 (0.14,0.23) | 0.32 (0.21,0.43) |
CI: confidence interval; HR-HPV: high-risk human papillomavirus; LR-HPV: low-risk human papillomavirus; East China: including Shan dong, Jiangsu, Anhui, Jiangxi, Zhejiang, Fujian and Shanghai; Central China: including Henan, Hubei and Hunan; North China: including Beijing, Tianjin, Hebei, Shanxi, and Inner Mongolia; Northwest China: including Ningxia, Xinjiang, Qinghai, Shanxi, and Gansu; Southwest China: Including Sichuan, Yunnan, Guizhou, Tibet, and Chongqing; Northeast China: including Liaoning, Jilin, and Heilongjiang; South China: Guangdong, Guangxi, and Hainan